From: James Ives
Sent: Tuesday, February 20, 2018 11:14 AM
To: [log in to unmask]
Subject: Parkinson's Disease - Feb 20, 2018 Edition
Researchers develop new method to map dopamine system in Parkinson's patients
Can't see this email? View it online
February 20, 2018
Parkinson's Disease
The latest Parkinson's disease news from News Medical
Researchers develop new method to map dopamine system in Parkinson's patients With the aid of a PET camera, researchers from Karolinska Institutet in Sweden have developed a new method for investigating the dopamine system in the brains of patients suffering from Parkinson's disease.
NIH scientists modify new RT-QuIC assay to detect Parkinson's, dementia with Lewy bodies National Institutes of Health scientists developing a rapid, practical test for the early diagnosis of prion diseases have modified the assay to offer the possibility of improving early diagnosis of Parkinson's disease and dementia with Lewy bodies.
Researchers uncover how excess calcium may influence development of Parkinson’s disease Researchers have found that excess levels of calcium in brain cells may lead to the formation of toxic clusters that are the hallmark of Parkinson's disease.
Traces of caffeine and its byproducts in the blood can be indicative of Parkinson’s disease Researchers at Juntendo University report in Neurology the potential use of blood levels of caffeine and its byproducts as biomarkers for Parkinson’s disease. The finding is promising for the development of a method enabling early identification of the disease.
New family of peptides in wasp's venom may help develop better Parkinson's treatments After being stung by a parasitic wasp, the American cockroach loses control of its behavior, becoming host to the wasp's egg.
Therapeutic target for glaucoma could have treatment ramifications for Alzheimer’s and Parkinson’s A therapeutic target to preserve vision in glaucoma patients could have treatment ramifications for age-related neurodegenerative disorders like Alzheimer's and Parkinson's, according to findings released today in the Proceedings of the National Academy of Sciences.
New study to test safety, efficacy of MRI-guided focused ultrasound to treat Parkinson's disease University of Maryland Medicine is leading a phase 3 study to test the safety and efficacy of using MRI-guided focused ultrasound on the brain in order to treat Parkinson's disease.
Website: www.news-medical.net
Email: [log in to unmask]
Telephone: +44 (0)161 457 7150
AZoNetwork UK Ltd.
NEO, 4th Floor
9 Charlotte Street, Manchester
M1 4ET, UK
Why did you receive this email?
You recently requested related information from us and asked to be notified of additional information.
Not interested anymore?
Update your Newsletter Subscriptions
Copyright © 2000-2018
Privacy Terms and Conditions
----------------------------------------------------------------------
To sign-off Parkinsn send a message to: mailto:[log in to unmask]
In the body of the message put: signoff parkinsn
